96 Talamine Court
Colorado Springs, CO 80907
Industry: Medical Appliances & Equipment
Full Time Employees: 374
The Spectranetics Corporation develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system using its excimer laser technology. The company's Excimer laser technology delivers relatively cool ultraviolet energy to remove arterial blockages, including plaque, calcium, and thrombus. It offers a range of proprietary laser devices designed for indications, including peripheral laser atherectomy in the upper and lower leg; and coronary laser atherectomy. The company's peripheral laser atherectomy products include TURBO Elite Catheters for peripheral laser atherectomy; TURBO-Booster for the TURBO elite laser catheters facilitating directed laser ablation of blockages in the main arteries at or above the knee; and Quick-Cross Support Catheter that supports catheters for use in the cardiovascular system to support and assist standard guidewires to facilitate initial crossing of the blockage. Its coronary laser atherectomy products comprise disposable catheters consisting of Rapid Exchange Catheter, Over-The-Wire Catheter, POINT 9 Catheter, and Quick-Cross Support Catheter. The Spectranetics Corporation also offers devices for the removal of infected, defective, or abandoned pacemaker and implantable cardiac defibrillators leads. The company's CVX-300 excimer laser unit includes Spectranetics Laser Sheath, a laser-assisted lead removal device; and Lead Locking Device, a mechanical device that assists in the removal of faulty leads by providing traction on the inner aspect of the leads, which are constructed of wire coils covered by insulating material. It operates in the United States, Canada, Mexico, South America, the Pacific Rim, and Australia. The Spectranetics Corporation was founded in 1984 and is based in Colorado Springs, Colorado.
Mr. John G. Schulte, 59
Chief Exec. Officer, Pres
Mr. Guy A. Childs, 42
Chief Financial Officer, Principal Accounting Officer, VP
Mr. Will McGuire, 45
Chief Operating Officer
Ms. Kelly W. Elliott RN MS, 46
VP of Clinical Affairs
Mr. Stephen D. Okland Jr., 44
VP of Sales and Marketing for the United States
Spectranetics Excimer laser system
The Excimer laser system is the only multi-functional laser system available. Its utility has been proven in many cardiac and vascular applications. The ‘cool’ laser uses pulsed ultraviolet laser energy to accurately ablate tissue. The CVX-300 generator is compatible with a range of Spectranetics products, the use of which is determined by the procedure undertaken.
Pacing lead extraction
Laser assisted removal of pacemaker leads is regarded as the gold standard therapy for patients requiring pacing lead explantation.
The Spectranetics Laser Sheath (SLS) is designed to allow safe and effective ablation of the fibrous tissue that binds pacing leads following implantation.
The Spectranetics Lead Locking device (LLD) is a useful addition to the portfolio. This locking stylet is placed down the inner core of the pacing lead undergoing removal. The LLD is then deployed and grips the entire inner surface of the core, allowing traction. Applying traction to the device then allows removal of lead. Should the LLD need to be removed, the device is completely removable.
Spectranetics offer a range of catheters to suit many interventional procedures. Most are ‘rapid exchange’ to allow compatibility with modern practice.
The Excimer laser system has been widely used in coronary interventions to:
· Debulk diffuse atherosclerotic disease.
· Treat in-stent restenosis.
· Cross chronic total occlusions.
· Ablate fibrous tissue in undilatable lesions.
· Ablate plaque within degenerated saphenous vein grafts.
· Dissolve thrombus in patients with acute myocardial infarction.
A comprehensive bibliography is available on request.
The success seen with laser revascularisation of coronary vessels has been translated to peripheral interventions. The Excimer laser has been approved for use in treating:
· Long, diffuse lower limb arterial disease.
· Critical limb ischaemia (CLI).
· Acute thrombotic occlusions.
· Chronic total occlusions.
Recent studies in populations presenting with CLI have demonstrated excellent limb salvage rates in patients with significant co-morbidities and those unsuitable for surgical treatment.
Further details on these and other studies can be found at www.spectranetics.com
Trailing P/E (ttm, intraday): 47.80
Forward P/E (fye 31-Dec-09): 53.84
Shares Outstanding: 31.61M
% Held by Insiders: 3.19%
% Held by Institutions: 68.70%
The CLiRpath System -- Vascular Surgery
The Detroit News reports that Dearborn's Oakwood Hospital is one of few hospitals in the country to perform a procedure, called CLiRpath, for treatment of peripheral vascular disease.
According to Spectranetics, the manufacturer of the laser system, the device has been FDA approved. Furthermore:
Current alternatives to treat refractory total occlusions common in advanced arterial disease are limited, and "treatment" often is amputation. With a 95% limb salvage rate* among survivors, the new CLiRpath system gives your CLI patients with total occlusions not crossable by a guidewire, a viable alternative in the fight against amputation. Used in conjunction with the CVX-300® laser system, CLiRpath Extreme® Catheters use "cool" ultraviolet excimer laser energy to cross total obstructions and restore straightline blood flow to the foot, which may facilitate wound healing.
The CVX-300 excimer laser is a pulsed system that vaporizes plaque and thrombus by delivering very high energy in extremely short pulses. The "cool" excimer laser ablates tissue on contact (about 50 microns from the catheter's tip) without inducing thermal damage to the treated artery.
Debulking with CLiRpath prior to balloon angioplasty transforms total occlusions not crossable by a guidewire and diffuse multilevel disease into more easily ballooned stenoses.
Great system, indeed. One of the most common methods to unblock thrombosed artery nowadays is to use a so-called Fogarty catheter (wire with an inflatable balloon at the tip), to surgically bypass the obstruction, or to amputate. One does not have to be a doctor to realize how sucky these options are.